FO
FT Options Portfolio holdings
AUM
$40M
This Quarter Return
-1.04%
1 Year Return
+13.03%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$75M
AUM Growth
+$75M
(+21%)
Cap. Flow
+$16M
Cap. Flow
% of AUM
21.36%
Top 10 Holdings %
Top 10 Hldgs %
58.2%
Holding
237
New
53
Increased
21
Reduced
13
Closed
31
Top Buys
| 1 |
MDVN
MEDIVATION, INC.
MDVN
|
$4.88M |
| 2 |
Biogen
BIIB
|
$3.27M |
| 3 |
Cal-Maine
CALM
|
$2.62M |
| 4 |
Bristol-Myers Squibb
BMY
|
$2.58M |
| 5 |
Apple
AAPL
|
$2.24M |
Top Sells
| 1 |
Baxter International
BAX
|
$4.11M |
| 2 |
Gilead Sciences
GILD
|
$1.88M |
| 3 |
IBM
IBM
|
$1.49M |
| 4 |
Chipotle Mexican Grill
CMG
|
$930K |
| 5 |
Expedia Group
EXPE
|
$914K |
Sector Composition
| 1 | Healthcare | 64.24% |
| 2 | Technology | 9.73% |
| 3 | Consumer Staples | 6.42% |
| 4 | Consumer Discretionary | 3.5% |
| 5 | Materials | 2.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Regeneron Pharmaceuticals
REGN
$61.5B
| $11M | 9.4% |
31,354
-1,805
| -5% | -$630K |
|
|
MDVN
2
DELISTED
MEDIVATION, INC.
MDVN
| $7.18M | 6.17% |
119,135
+80,980
| +212% | +$4.88M |
|
3
Abbott
ABT
$231B
| $5M | 4.3% |
127,252
-8,048
| -6% | -$316K |
|
|
4
Cal-Maine
CALM
$5.61B
| $3.64M | 3.12% |
82,081
+59,189
| +259% | +$2.62M |
|
|
5
Biogen
BIIB
$19.4B
| $3.54M | 3.04% |
14,632
+13,516
| +1,211% | +$3.27M |
|
|
OTIC
6
DELISTED
Otonomy, Inc.
OTIC
| $3.06M | 2.63% |
192,785
+36,348
| +23% | +$577K |
|
|
7
Apple
AAPL
$3.45T
| $2.76M | 2.37% |
28,844
+23,487
| +438% | +$2.24M |
|
8
Akebia Therapeutics
AKBA
$833M
| $2.75M | 2.36% |
367,276
-22,643
| -6% | -$169K |
|
|
9
Bristol-Myers Squibb
BMY
$96B
| $2.58M | 2.22% |
+35,075
| New | +$2.58M |
|
|
ALR
10
DELISTED
Alere Inc
ALR
| $2.22M | 1.9% |
53,163
+17,000
| +47% | +$709K |
|
11
BioMarin Pharmaceuticals
BMRN
$11.2B
| $1.66M | 1.43% |
+21,373
| New | +$1.66M |
|
|
POT
12
DELISTED
Potash Corp Of Saskatchewan
POT
| $1.56M | 1.34% |
96,080
+36,080
| +60% | +$586K |
|
|
ICPT
13
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.54M | 1.32% |
10,779
-4,535
| -30% | -$647K |
|
14
Humana
HUM
$36.5B
| $1.41M | 1.21% |
7,850
+1,272
| +19% | +$229K |
|
15
Sarepta Therapeutics
SRPT
$1.78B
| $1.16M | 1% |
+60,908
| New | +$1.16M |
|
|
YHOO
16
DELISTED
Yahoo Inc
YHOO
| $1.14M | 0.98% |
30,341
+25,100
| +479% | +$943K |
|
17
Rocket Pharmaceuticals
RCKT
$354M
| $1.08M | 0.93% |
144,751
-24,800
| -15% | -$185K |
|
|
CASC
18
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $1.05M | 0.91% |
1,117,661
+102,054
| +10% | +$96.2K |
|
19
Johnson & Johnson
JNJ
$427B
| $1.04M | 0.9% |
+8,606
| New | +$1.04M |
|
|
ALXN
20
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $1.01M | 0.87% |
8,673
+5,100
| +143% | +$596K |
|
21
Ligand Pharmaceuticals
LGND
$3.15B
| $1.01M | 0.87% |
8,467
+7,603
| +880% | +$907K |
|
|
AGN
22
DELISTED
Allergan plc
AGN
| $933K | 0.8% |
4,038
+2,558
| +173% | +$591K |
|
|
CMRX
23
DELISTED
Chimerix, Inc.
CMRX
| $866K | 0.74% |
220,266
-67,446
| -23% | -$265K |
|
24
Esperion Therapeutics
ESPR
$448M
| $798K | 0.69% |
80,799
+49,503
| +158% | +$489K |
|
25
Microsoft
MSFT
$3.77T
| $683K | 0.59% |
+13,345
| New | +$683K |
|